Mira Pharmaceuticals, Inc. SEC filings MIRA
Mira Pharmaceuticals, Inc. has 198 filings in SEC EDGAR's recent list, going back to Jun 29, 2022. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (regulation fd disclosure).
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 16, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 1, 2026 | Sep 1, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 31, 2026 | Jul 27, 2026 |
| DEF 14A | Proxy statement | Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2026 | Jul 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 6, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 25, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 8, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 27, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Other events
|
May 13, 2026 | May 12, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 23, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Other events
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Other events
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Other events
|
Dec 5, 2025 | Dec 5, 2025 |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Other events
|
Oct 16, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Other events
|
Oct 15, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
|
Sep 30, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Other events
|
Sep 22, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Other events
|
Sep 15, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 11, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Other events
|
Aug 19, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| DEFM14A | Filing | Aug 8, 2025 | — |
| DEFA14A | Additional proxy material | Aug 8, 2025 | — |
| PRER14A | Filing | Jul 29, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Other events
|
Jul 28, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Other events
|
Jul 10, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Other events
|
Jul 8, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Other events
|
Jul 2, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Other events
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Other events
|
Jun 17, 2025 | Jun 17, 2025 |
| PREM14A | Filing | Jun 17, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Other events
|
May 28, 2025 | May 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
May 21, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Other events
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Other events
|
Apr 23, 2025 | Apr 23, 2025 |
| 10-K/A | Amended annual report | Apr 17, 2025 | Dec 31, 2024 |
| 424B5 | Prospectus supplement | Apr 16, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 16, 2025 | Apr 16, 2025 |
| 10-K/A | Amended annual report | Apr 15, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 11, 2025 | Apr 8, 2025 |
| 8-K |
Current report
Other events
|
Apr 1, 2025 | Apr 1, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 24, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Other events
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Other events
|
Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Auditor change
|
Dec 20, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Other events
|
Dec 19, 2024 | Dec 19, 2024 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Other events
|
Nov 19, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 25, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Other events
|
Oct 21, 2024 | Oct 21, 2024 |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| S-8 | Employee stock plan registration | Sep 27, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Sep 12, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Other events
|
Aug 23, 2024 | Aug 23, 2024 |
| EFFECT | Filing | Aug 16, 2024 | — |
| 10-Q/A | Amended quarterly report | Aug 16, 2024 | Jun 30, 2024 |
| CORRESP | Letter to the SEC | Aug 15, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| S-3 | Shelf registration | Aug 12, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Other events
|
Aug 8, 2024 | Aug 7, 2024 |
| DEFA14A | Additional proxy material | Jul 26, 2024 | — |
| DEF 14A | Proxy statement | Jul 26, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Other events
|
Jul 24, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Other events
|
Jul 19, 2024 | Jul 19, 2024 |
| 8-K |
Current report
Listing notice, Other events
|
Jul 12, 2024 | Jul 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 28, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Officer or director change
|
May 29, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 13, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Other events
|
Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 17, 2024 | Jan 15, 2024 |
| EFFECT | Filing | Dec 27, 2023 | — |
| CORRESP | Letter to the SEC | Dec 22, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2023 | — |
| S-1 | Registration statement | Dec 18, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2023 | Dec 1, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Nov 20, 2023 | Nov 14, 2023 |
| 424B3 | Prospectus | Nov 14, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 25, 2023 | Oct 19, 2023 |
| 424B3 | Prospectus | Sep 18, 2023 | — |
| 10-Q | Quarterly report | Sep 15, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 31, 2023 | Aug 28, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 7, 2023 | Aug 2, 2023 |
| 424B4 | Prospectus | Aug 4, 2023 | — |
| 424B1 | Filing | Aug 4, 2023 | — |
| EFFECT | Filing | Aug 2, 2023 | — |
| CERT | Filing | Jul 31, 2023 | — |
| CORRESP | Letter to the SEC | Jul 31, 2023 | — |
| CORRESP | Letter to the SEC | Jul 31, 2023 | — |
| 8-A12B | Filing | Jul 31, 2023 | — |
| S-1/A | Amended registration statement | Jul 28, 2023 | — |
| S-1/A | Amended registration statement | Jul 25, 2023 | — |
| S-1/A | Amended registration statement | Jul 21, 2023 | — |
| S-1/A | Amended registration statement | Jul 18, 2023 | — |
| CORRESP | Letter to the SEC | Jul 14, 2023 | — |
| S-1/A | Amended registration statement | Jul 14, 2023 | — |
| CORRESP | Letter to the SEC | Jul 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2023 | — |
| CORRESP | Letter to the SEC | Jun 29, 2023 | — |
| S-1 | Registration statement | Jun 29, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2023 | — |
| DRSLTR | Filing | Jun 8, 2023 | — |
| DRS/A | Filing | Jun 8, 2023 | — |
| UPLOAD | Letter from the SEC | May 30, 2023 | — |
| DRS/A | Filing | May 2, 2023 | — |
| D | Filing | Aug 1, 2022 | — |
| D | Filing | Aug 1, 2022 | — |
| DRS | Filing | Jun 29, 2022 | — |
Showing 136 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIRA (Nasdaq)
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1904286
- Former names
- Mira1a Therapeutics, Inc. (until May 2, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.